Medicaid coverage of weight-loss drugs could cost Indiana up to $70 million a year
Indiana’s Medicaid program estimates the Biden administration’s proposal to expand coverage of weight-loss treatment for people with obesity could cost it up to $70 million a year, covering up to 20% of eligible enrollees.
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.
For weight loss drugs like Ozempic and Wegovy, 2024 was a big year. More patients are relying on them to manage their weight, treat diabetes, or prevent heart attacks and strokes. And while they are ...
11don MSN
GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...
A study in pigs has shown that the active ingredient in Ozempic and Wegovy directly boosts heart health, in addition to the ...
Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also increasing in popularity as weight-loss options for people around the world. When ...
There are currently three medications (GLP-1s) on the market that the FDA has specifically approved to treat obesity — ...
Millions of people have used Ozempic and similar drugs to lose weight, but are unhappy with the way their faces change, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback